Giapreza

Chemical Nameangiotensin II
Dosage FormInjection (intravenous; 2.5 mg/mL, 5 mg/2 mL)
Drug ClassHormones
SystemCardiovascular
CompanyLa Jolla Pharmaceuticals
Approval Year2017

Indication

  • To increase blood pressure in adults with septic or other distributive shock.
Last updated on 11/1/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Giapreza (angiotensin II) Prescribing Information2017La Jolla Pharmaceutical Company, San Diego, CA